Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients

(2014) Reiji Yoshimura et al.   Annals of General Psychiatry

Upregulation of blood proBDNF and its receptors in major depression

(2013) Li Zhou et al.   JOURNAL OF AFFECTIVE DISORDERS

Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine

(2013) Hidenaga Yamamori et al.   NEUROSCIENCE LETTERS

Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder

(2012) Taisuke Yoshida et al.   PLoS One

Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis

(2010) M J Green et al.   MOLECULAR PSYCHIATRY

Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions

(2010) Kenji Hashimoto   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients

(2010) Reiji Yoshimura et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Brain-derived neurotrophic factor: role in depression and suicide

(2010) Yogesh Dwivedi   Neuropsychiatric Disease and Treatment

Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia

(2009) Naoki Goto et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Whither proBDNF?

(2009) Philip A Barker   NATURE NEUROSCIENCE